SARTORIUS STEDIM BIOTECH earnings per share and revenue

56S1 earnings per share for the last quarter are 0.76 EUR whereas the estimation was 0.80 EUR which accounts for -4.68% surprise. Company revenue for the same period amounts to 655.40 M EUR despite the estimated figure of 685.76 M EUR. Estimated earnings per share for the next quarter are 0.97 EUR, and revenue is expected to reach 710.61 M EUR. Also watch annual changes over time to get a bigger picture of 56S1 earnings per share and revenue dynamics.